RNA Analysis Market Size to Hit US$ 30.48 BN by 2030

The global RNA Analysis market size is expected to hit around US$ 30.48 billion by 2030 and is projected to grow at a CAGR of 14.44% during forecast period 2021 to 2030.

The global RNA Analysis market size is expected to hit around US$ 30.48 billion by 2030 and is projected to grow at a CAGR of 14.44% during forecast period 2021 to 2030.

Growth Factors

Technological advancements in this market can be attributed to the increasing applications of transcriptome sequencing into life science for capturing polyadenylated RNA.

Get the sample copy of report@ https://www.visionresearchreports.com/report/sample/39075

RNA Analysis Market Size 2022 to 2030


The growing need for analyzing a huge number of genes to understand the gene-to-drug interactions is anticipated to enhance the application of transcriptomics technologies in discovery applications and drug development. For instance, transcriptome profiles of COVID-19 patients have been analyzed to examine the disease prognosis and management. Collaborations between research institutes for the use of transcriptomics in various applications would drive market growth.

Report Coverage

Report Scope

Details

Market Size

US$ 30.48 billion by 2030

Growth Rate

CAGR of 14.44% From 2021 to 2030

Largest Market

North America

Base Year

2021

Forecast Period

2021 to 2030

Segments Covered

Technology, Product, Application, End-use

Regional Scope

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Companies Mentioned

Agilent Technologies; Bio-Rad Laboratories, Inc.; F. Hoffmann-La Roche AG; Illumina, Inc.;QIAGEN; Thermo Fisher Scientific, Inc; Eurofins Scientific; Merck KGaA; Pacific Bioscience of California, Inc; Affymetrix, Inc; Danaher Corporation; Promega

 

By Technology Analysis

Based on technology, real-time-PCR (qPCR) technology dominated the market with the largest revenue share of more than 56% in 2020 due to increased use of PCR for COVID-19 diagnostic across the globe. 

The technology is considered to be highly sensitive and quantitative and one of the most suitable methods for interrogating a comparatively small number of transcripts in a broad set of samples. PCR offers relatively high-sensitivity detection of SARS-CoV-2, evaluation of viral RNA in various types of clinical samples, detecting SARS-CoV-2 mutations, and evaluation of anti-SARS-CoV-2 drugs.

The sequencing segment is anticipated to witness substantial growth over the forecast years owing to advancements in the next-generation and SMRT sequencing technology. The presence of several companies providing single-cell RNA sequencing services and the advent of bioinformatics algorithms are also driving the growth of this market.

Ask here for more details@ https://www.visionresearchreports.com/report/enquiry/39075

By Product Analysis

Based on products, the kits & reagents segment accounted for the largest revenue share of over 58% in2020. Rising requirements for high-quality reagents and kits coupled with repeated use of reagents and media in transcriptome studies drive the segment growth. 

Growing R&D activities in the pharmaceutical sector and increasing government investments in life science research are the major factors expected to fuel this market for consumables.NGS roots have begun with the adaptation of some SMART cDNA synthesis technology mainly for RNA-sequencing applications. 

By Application Analysis

The Infectious diseases and pathogenesis segment accounted for a substantial market share of more than 20% in 2020 and is closely followed by alternative RNA splicing applications. Identification of susceptible cells is crucial for understanding the pathogenic mechanism. 

The RNA structure and molecular dynamics segment is expected to expand at a significant CAGR from 2021 to 2028 as pharmaceutical importance for RNA in the development of a new drug is gradually growing.

By End-use Analysis

The government institutes & academic centers segment reported the highest revenue share of over 32% in 2020. The rising adoption of high throughput technologies for the effective process of RNA analysis by government institutes and academic centersis driving the segment growth.

Research in drug discovery is also contributing to the market that is followed by clinical diagnostics. For instance, in April 2021, researchers developed TORNADO-seq, an RNA sequencing-based drug discovery platform to monitor the expression of the large gene for a detailed study of cellular phenotypes in organoids.

The Italian Institute of Technology has signed a partnership agreement with European Molecular Biology Laboratory to expand their collaboration in research. This collaboration is anticipated to strengthen their database and share resources for the study. 

By Regional Analysis

North America accounted for the maximum revenue share of more than 46% in 2020. The growth is attributed to the rapid development of structure-based drug designs, increasing focus on transcriptomics research, and high investment in biopharmaceutical research and development. 

Growing investments by governments &enterprises are accelerating biotechnology research in Asia Pacific countries. The Japanese government and non-government organizations are highly supportive of the growth of biotechnology research in the country and provide funds to research in the fields of medicine and life sciences. 
 

Increasing focus on Asia Pacific countries is owing to the low-cost manufacturing services, is expected to provide growth opportunities for the manufacturers.

Key Players 

  • Agilent Technologies, Inc.
  • F. Hoffmann-La Roche AG
  • Illumina, Inc.
  • QIAGEN
  • Thermo Fisher Scientific, Inc.
  • Eurofins Scientific
  • Merck KGaA
  • Bio-Rad Laboratories, Inc.
  • Pacific Bioscience of California, Inc.
  • Affymetrix, Inc.
  • Danaher Corporation
  • Promega

Market Segmentation

  • By Technology 
    • Real Time-PCR (qPCR) Technology
    • Microarray Technology
    • Sequencing Technology
    • Others
  • By Product 
    • Instruments
    • Kits & Reagents
      • miRNA & siRNA
      • Reverse Transcriptases& RT-PCR
      • RNA Extraction & Purification
      • RNA Interference
      • Others
    • Services
  • By Application 
    • Construction of RNA Expression Atlas
    • Epigenetics
    • Infectious Diseases and Pathogenesis
    • Alternative RNA Splicing
    • RNA Structure & Molecular Dynamics
    • Development & Delivery of RNA Therapeutics
    • Others
  • By End-use 
    • Government Institutes & Academic Centers
    • Pharmaceutical & Biotechnology Companies
    • Contract Research Organizations (CROs)
    • Hospitals & Clinics
  • Regional
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • MEA

Click Here to View Full Report Table of Contents

Buy this Premium Research Report@ https://www.visionresearchreports.com/report/cart/39075

You can place an order or ask any questions, please feel free to contact at sales@visionresearchreports.com | +1 9197 992 333